Bulletin
Investor Alert

Concert Pharmaceuticals Inc.

NAS: CNCE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201149635/composite

$

8.93

Change

0.00 0.00%

Volume

Volume 1,470

Sep 25, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201149635/composite

Previous close

$ 9.25

$ 8.93

Change

-0.32 -3.46%

Day low

Day high

$8.69

$9.42

Open
Open: 9.12

52 week low

52 week high

$5.36

$13.09

Open

Market cap

$265.03M

Average volume

115,085

P/E ratio

N/A

Rev. per Employee

$147,958

EPS

-2.70

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cnce

MarketWatch News on CNCE

  1. Concert Pharmaceuticals started at buy with $30 stock price target at SunTrust RH

    8:36 a.m. June 24, 2019

    - Tomi Kilgore

  2. Concert Pharmaceuticals stock plunges 17% after disappointing patent ruling

    2:58 p.m. April 8, 2019

    - Tomi Kilgore

  3. Concert Pharmaceuticals started at neutral with $17 stock fair value estimate at Janney

    7:25 a.m. Sept. 13, 2018

    - Tomi Kilgore

  4. Concert Pharma stock drops 11% after FDA puts hair loss drug on clinical hold

    9:21 a.m. May 17, 2017

    - Emma Court

  5. Charting the Market

    1:35 a.m. March 11, 2017

    - Barron's Online

  6. Harry Boxer’s six biotechnology stocks to watch

    2:55 p.m. March 7, 2017

    - Harry Boxer

  7. Concert Pharmaceuticals' stock resumes trade, soars 22% premarket

    8:46 a.m. March 6, 2017

    - Tomi Kilgore

  8. Concert Pharamceuticals' stock on track to open at 7-month high

    8:47 a.m. March 6, 2017

    - Tomi Kilgore

  9. Concert Pharamceuticals' stock set to resume trade at 7:45 a.m. ET

    8:23 a.m. March 6, 2017

    - Tomi Kilgore

  10. Vertex to buy Concert Pharmaceuticals' cystic fibrosis treatment for $160 mln and potential milestone payments

    8:06 a.m. March 6, 2017

    - Tomi Kilgore

  11. Concert Pharmaceuticals' stock halted for news

    8:06 a.m. March 6, 2017

    - Tomi Kilgore

  12. Concert Pharmaceuticals started at buy with $23 stock price target at Stifel Nicolaus

    7:27 a.m. July 1, 2016

    - Tomi Kilgore

  13. Sector rotation strengthens bear case

    11:23 a.m. Sept. 28, 2015

    - Michael Ashbaugh

  14. Three Biotechs Ready to Partner Up

    10:30 a.m. Sept. 8, 2014

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/cnce

Other News on CNCE

  1. Trillium (TRIL) Soars: Stock Adds 6% in Session

    8:38 a.m. Sept. 15, 2020

    - Zacks.com

  2. 10-Q: CONCERT PHARMACEUTICALS, INC.

    7:23 a.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Concert (CNCE) Upgraded to Buy: Here's Why

    12:00 p.m. June 30, 2020

    - Zacks.com

  4. Catalyst (CPRX) Q1 Earnings Beat Estimates, Revenues Miss

    10:17 a.m. May 12, 2020

    - Zacks.com

  5. 10-Q: CONCERT PHARMACEUTICALS, INC.

    7:28 a.m. April 30, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Concert (CNCE) Moves to Buy: Rationale Behind the Upgrade

    12:00 p.m. April 29, 2020

    - Zacks.com

  7. Stocks To Watch: 0% To The Rescue?

    8:49 a.m. March 14, 2020

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/cnce

Press Releases on CNCE

  1. Alopecia Treatment Market 2020-2029 / Emerging Trends And Forecast

    4:21 a.m. Sept. 15, 2020

    - AmericaNewsHour

  2. Concert Pharmaceuticals to Present at Upcoming Investor Conferences

    7:00 a.m. Sept. 8, 2020

    - BusinessWire - BZX

  3. Concert Pharmaceuticals to Present at The JMP Securities CNS Forum

    6:00 a.m. Aug. 18, 2020

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.